본문 바로가기
KERD
논문KCI 등재

Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report

Pricilla Yani Gunawan|Pamela Tiffani|Lilie Lalisang
대한정신약물학회 (Korean College of Neuropsychopharmacology)|2022.11|Clinical Psychopharmacology and Neuroscience|제20권 제4호|pp. 777-780|DOI 10.9758/cpn.2022.20.4.777

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

VaccinationSARS-CoV-2Guillain-Barre syndromeFacial paralysis.

초록

After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis.

Abstract

After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis.

참고문헌 (31)

  1. Finsterer J, "Exacerbating Guillain-Barré syndrome eight days after vector-based COVID-19 vaccination", Case Rep Infect Dis, 2021, pp.3619131~ (2021)
  2. Yuki N, "Guillain-Barré syndrome", N Engl J Med, 366, pp.2294~2304 (2012)
  3. Hughes RA, "Clinical and epidemiologic features of Guillain-Barré syndrome", J Infect Dis, 176(Suppl 2), pp.S92~S98 (1997)
  4. Winner SJ, "Age-specific incidence of Guillain-Barrésyndrome in Oxfordshire", Q J Med, 77, pp.1297~1304 (1990)
  5. Haber P, "Vaccines and Guillain-Barré syndrome", Drug Saf, 32, pp.309~323 (2009)
  6. Padroni M, "Barré syndrome following COVID-19 : new infection, old complication?", J Neurol, 267, pp.1877~1879 (2020)
  7. Poropatich KO, "Quantifying the association between Campylobacter infection and Guillain-Barrésyndrome : a systematic review", J Health Popul Nutr, 28, pp.545~552 (2010)
  8. Hadden RD, "Preceding infections, immune factors, and outcome in Guillain-Barré syndrome", Neurology, 56, pp.758~765 (2001)
  9. Fokke C, "Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria", Brain, 137(Pt 1), pp.33~43 (2014)
  10. Orlikowski D, "Guillain-Barré syndrome following primary cytomegalovirus infection : a prospective cohort study", Clin Infect Dis, 52, pp.837~844 (2011)
  11. Kang JH, "Increased risk of Guillain-Barré syndrome following recent herpes zoster : a population-based study across Taiwan", Clin Infect Dis, 51, pp.525~530 (2010)
  12. Lunn MP, "COVID-19 vaccine and Guillain-Barré syndrome : let’s not leap to associations", Brain, 144, pp.357~360 (2021)
  13. Woo EJ, "Association of receipt of the Ad26.COV2.S COVID-19 vaccine with presumptive Guillain-Barré syndrome, February-July 2021", JAMA, 326, pp.1606~1613 (2021)
  14. Finsterer J, "Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients", Clinics(Sao Paulo), 76, pp.e3286~ (2021)
  15. Allen CM, "Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination", Ann Neurol, 90, pp.315~318 (2021)
  16. McKean N, "Guillain-Barré syndrome after COVID-19vaccination", BMJ Case Rep, 14, pp.e244125~ (2021)
  17. Arce Gálveza L, "Guillain-Barre syndrome after vaccination for COVID-19. The first report in Latin America", Neurol Perspect, 1, pp.236~238 (2021)
  18. Toscano G, "Guillain-Barré syndrome associated with SARS-CoV-2", N Engl J Med, 382, pp.2574~2576 (2020)
  19. Sedaghat Z, "Guillain Barre syndrome associated with COVID-19 infection : a case report", J Clin Neurosci, 76, pp.233~235 (2020)
  20. Virani A, "Guillain-Barré syndrome associated with SARS-CoV-2infection", IDCases, 20, pp.e00771~ (2020)
  21. Alberti P, "Guillain-Barré syndrome related to COVID-19 infection", Neurol Neuroimmunol Neuroinflamm, 7, pp.e741~ (2020)
  22. Aladawi M, "Guillain Barre syndrome as a complication of COVID-19 : a systematic review", Can J Neurol Sci, 49, pp.38~48 (2022)
  23. Shoenfeld Y, "Vaccination and autoimmunity-‘vaccinosis’ : a dangerous liaison?", J Autoimmun, 14, pp.1~10 (2000)
  24. Chen RT, "Challenges and controversies in immunization safety", Infect Dis Clin North Am, 15, pp.21~39 (2001)
  25. McCombe PA, "Studies of HLA associations in male and female patients with Guillain-Barré syndrome(GBS)and chronic inflammatory demyelinating polyradiculoneuropathy(CIDP)", J Neuroimmunol, 180, pp.172~177 (2006)
  26. Caporale CM, "Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes", J Neuroimmunol, 177, pp.112~118 (2006)
  27. Jin PP, "Human leukocyte antigen DQB1(HLA-DQB1)polymorphisms and the risk for Guillain-Barré syndrome : a systematic review and meta-analysis", PLoS One, 10, pp.e0131374~ (2015)
  28. Patone M, "Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection", Nat Med, 27, pp.2144~2153 (2021)
  29. Wan EYF, "Bell’s palsy following vaccination with mRNA(BNT162b2)and inactivated(CoronaVac)SARS-CoV-2 vaccines : a case series and nested case-control study", Lancet Infect Dis, 22, pp.64~72 (2022)
  30. Kuitwaard K, "Recurrences, vaccinations and long-term symptoms in GBS and CIDP", J Peripher Nerv Syst, 14, pp.310~315 (2009)
  31. Burrows A, "Sequential contralateral facial nerve palsies following COVID-19 vaccination first and second doses", BMJ Case Rep, 14, pp.e243829~ (2021)

관련 논문AI추천

Guillain-Barré Syndrome Caused by Swine Influenza(H1N1) Vaccination: A Case Report박용재, 서은숙대한소아신경학회 · 대한소아신경학회지2010 · 제18권 제1호Guillain-Barré Syndrome Following the ChAdOx1-S/nCoV-19 Vaccine: A Case Report오성일, 이석윤대한근전도전기진단의학회 · 대한근전도 전기진단의학회지2022 · 제24권 제1호Reports of Guillain–Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS DatabaseAnna Bashmakov, Charles Andrews, Danuel Snelgrove, Julio A. Chalela, Niren Kapoor대한신경과학회 · Journal of Clinical Neurology2023 · 제19권 제2호BNT162b2 코로나19 백신 접종 이후 발생한 비정형경과를 보인 기얭-바레증후군강규식, 김병건, 유일한, 이웅우, 이정주, 이형철대한신경과학회 · 대한신경과학회지2022 · 제40권 제4호독감 예방 접종 후에 발생한 길랑-바레 증후군 - 증례 보고 -김지영, 김희진, 박기덕, 오지영대한근전도전기진단의학회 · 대한근전도 전기진단의학회지2009 · 제11권 제1호Neurological Adverse Reactions to SARS-CoV-2 VaccinesJosef Finsterer대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2023 · 제21권 제2호

이 간행물의 다른 논문 (19건)

Clinical Utility of Fluid Biomarker in Depressive DisorderAlessandro Serrettipp. 585-591Efficacy of Olanzapine in Anxiety Dimension of Schizophrenia: A Systematic Review of Randomized Controlled TrialsChiara Amendola, Ilaria Casolaro, Stefano Damiani, Calogero Crapanzanopp. 592-599Botulinum Toxin in Facial Aesthetics Affects the Emotion Process: A Meta-analysis of Randomized Controlled TrialsDelane Viana Gondim, Ana Carolina de Figueiredo Costa, Everton Cavalcante da Silvapp. 600-608Prediction Models for Suicide Attempts among Adolescents Using Machine Learning TechniquesJu-Won Baek, Bung-Nyun Kim, Chan-Mo Yang, Sang Yeol Lee, Jae Seok Limpp. 609-620Cerebellar Gray Matter Volume and its Role in Executive Function, and Attention: Sex Differences by Age in AdolescentsYerin Hyun, Subin Park, Seung-Yup Lee, 김보라, 박민현, 정규인, Bung-Nyun Kim, Bumhee Park, Hayeon Kim, Shin Young Kim, Jiyea Kimpp. 621-634
원문 보기